Table 1 Proportion of patients in groups 2 and 3 with upregulated expression of the indicated cluster 6 genes
Resectable (%) | Metastatic (%) | |||
---|---|---|---|---|
Genea | Group 2 | Group 3 | Group 2 | Group 3 |
ACTN1 | 42 | 5 | 46 | 8 |
ACTN4 | 45 | 16 | 46 | 8 |
ACTB | 52 | 14 | 54 | 25 |
MTOR | 52 | 22 | 52 | 17 |
AKT1 | 33 | 35 | 38 | 25 |
AKT2 | 48 | 19 | 54 | 8 |
CD44 | 39 | 16 | 92 | 0 |
ITGB1 | 42 | 3 | 23 | 0 |